Detalhe da pesquisa
1.
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Breast Cancer Res;
23(1): 57, 2021 05 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34020697
2.
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Int J Cancer;
145(7): 1902-1912, 2019 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30859564
3.
Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration.
Neurobiol Dis;
102: 21-37, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28237315
4.
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers.
Cancer Res;
84(1): 17-25, 2024 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37801608
5.
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.
Mol Cancer Ther;
22(2): 205-214, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36223547
6.
HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.
Mol Oncol;
17(10): 2017-2028, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36852691
7.
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.
Nat Commun;
14(1): 4221, 2023 07 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37452026
8.
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Nat Commun;
14(1): 1958, 2023 04 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37029129
9.
H3K27me3 conditions chemotolerance in triple-negative breast cancer.
Nat Genet;
54(4): 459-468, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35410383
10.
Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
Oncogene;
39(25): 4781-4797, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32307447
11.
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
Nat Commun;
11(1): 4053, 2020 08 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32792481
12.
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Sci Transl Med;
12(531)2020 02 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32075943
13.
Lactococcus lactis is an Efficient Expression System for Mammalian Membrane Proteins Involved in Liver Detoxification, CYP3A4, and MGST1.
Mol Biotechnol;
58(4): 299-310, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26961909